Corvus Pharmaceuticals Inc. Insider Trading

CRVS

⊜ Compare

Last 12 months

Insiders bought 334K on the open market and sold nothing.

Net open-market

+334K

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Jun 2026

Jun 11, 2026

Get an email when CRVS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 11	David Scott Moore Director	Bought	21,700	$11.53	250K	New	Form 4
May 18	Richard A Md Miller President and CEO	Bought 2 parts	6,932	$12.04 average	83K	0.3%	Form 4
Jun 27, 2025	Orbimed Advisors LLC Large holder	SoldNo plan	1,176,332	$4.16	$4.89M	14%	Form 4
Jun 27, 2025	Peter A. Thompson Director	SoldNo plan	1,176,332	$4.16	$4.89M	14%	Form 4

Jun 11
David Scott Moore
Director · bought 21,700 at $11.53
250K
New position
May 18
Richard A Md Miller
President and CEO · bought 6,932 at avg $12.04
83K
0.3% of stake
Jun 27, 2025No plan
Orbimed Advisors LLC
Large holder · sold 1,176,332 at $4.16
$4.89M
14% of stake
Jun 27, 2025No plan
Peter A. Thompson
Director · sold 1,176,332 at $4.16
$4.89M
14% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CRVS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CRVS

CompareIntrinsic value

FHTXFoghorn Therapeutics Inc.

$2.10-1.41%40

NATRNature's Sunshine Products Inc.

$12.84+6.38%70

EVMNEvommune, Inc.

$6.04+1.68%35

VSTMVerastem Inc.

$9.85+0.82%40

ARCTArcturus Therapeutics Holdings Inc.

$10.87+13.94%13

XERSXeris Biopharma Holdings, Inc.

$10.46+1.06%30

AMLXAmylyx Pharmaceuticals, Inc.

$29.40+0.68%10

JANXJanux Therapeutics Inc.

$18.18+2.02%40

Held by ETFs

CRVS is in 33 US ETFs. The largest of them, with CRVS's weight in each:

Spot a number that looks wrong? Check it in CRVS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CRVS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.